An International Organization Dedicated to  Finding a Cure for Fibrodysplasia Ossificans Progressiva (FOP) Began with a Group of Eleven Concerned Pen Pals

Three cases of fibrodysplasia ossificans progressiva (FOP) a rare genetic disease, were reported recently in Stat’s health issue. Wendy’s Story Wendy Weldon was a brave little nine years old when she…

Continue Reading An International Organization Dedicated to  Finding a Cure for Fibrodysplasia Ossificans Progressiva (FOP) Began with a Group of Eleven Concerned Pen Pals

Patient Worthy is Excited to Announce a New Partnership with The B.L.A.I.R. Connection!

A New Partnership Patient Worthy is honored and excited to announce our new partnership with The B.L.A.I.R. Connection. The B.L.A.I.R. Connection was founded by Grey Chapin who knows firsthand what…

Continue Reading Patient Worthy is Excited to Announce a New Partnership with The B.L.A.I.R. Connection!
The Department of Education’s 2020 Budget is Requesting Cuts to the Special Olympics and Special Education. What Does This Mean for Rare Patients?
Pexels / Pixabay

The Department of Education’s 2020 Budget is Requesting Cuts to the Special Olympics and Special Education. What Does This Mean for Rare Patients?

If you are an avid follower of the latest news, then you have probably heard about one the latest sensational headlines to come out of DC lately: the US Department…

Continue Reading The Department of Education’s 2020 Budget is Requesting Cuts to the Special Olympics and Special Education. What Does This Mean for Rare Patients?

Birth of Healthy Baby Monkey Indicates Promise of New Technique To Preserve Fertility of Childhood Cancer Patients

As the field of medicine has continually advanced, more and more children (now approximately 80%) are surviving cancer diagnoses. It's amazing. It also means that researchers are able to focus…

Continue Reading Birth of Healthy Baby Monkey Indicates Promise of New Technique To Preserve Fertility of Childhood Cancer Patients

New Potential Combination Therapy for Acute Myelogenous Leukemia has Received Breakthrough Therapy Designation

Acute Myelogenous Leukemia Acute myelogenous leukemia (AML) is a rare blood cancer whose prevalence increases with age. There are still extremely limited treatment options for AML and the five-year survival…

Continue Reading New Potential Combination Therapy for Acute Myelogenous Leukemia has Received Breakthrough Therapy Designation

Yet Another Study Shows the Dire Need for More Diversity in Medical Research

A recent study published in Cell has exhibited the scientific community's negligence for conducting research that includes an adequate representation of non-Europeans. Specifically, it showed that 78% of patients in genomic…

Continue Reading Yet Another Study Shows the Dire Need for More Diversity in Medical Research

Recent Discovery Finds a New Genetic Basis for Leukoencephalopathy

According to a story from The McGill Tribune, a little girl named Mathilde Poliquin recently died at the Montreal Children's Hospital. She was only two and half months old and…

Continue Reading Recent Discovery Finds a New Genetic Basis for Leukoencephalopathy
Phase 3 Myelodysplastic Syndromes Trial Reaches Enrollment Milestone
DarkoStojanovic / Pixabay

Phase 3 Myelodysplastic Syndromes Trial Reaches Enrollment Milestone

According to a story from sectorpublishingintelligence.co.uk, the biopharmaceutical company Onconova Therapeutics, Inc. recently announced that they have successfully surpassed the 75 percent milestone for enrollment in the company's Phase 3…

Continue Reading Phase 3 Myelodysplastic Syndromes Trial Reaches Enrollment Milestone
Results from Three Clinical Trials for Urea Cycle Disorders and Cirrhosis Coming by the End of the Year
source: pixabay.com

Results from Three Clinical Trials for Urea Cycle Disorders and Cirrhosis Coming by the End of the Year

Three non-investigational New Drug clinical studies are underway for Urea Cycle Disorders (UCD) and various forms of cirrhosis, initiated by Kaleido Biosciences. Dosing has been initiated in each of these…

Continue Reading Results from Three Clinical Trials for Urea Cycle Disorders and Cirrhosis Coming by the End of the Year

Extremely Positive Results from Systemic Juvenile Idiopathic Arthritis 5-year Follow-Up Study in the EU

Extremely positive results have just been announced from a 5-year follow-up study of a systemic juvenile idiopathic arthritis (sJIA) treatment called Kineret. This treatment has been approved for use in…

Continue Reading Extremely Positive Results from Systemic Juvenile Idiopathic Arthritis 5-year Follow-Up Study in the EU